Gout treatment market to be driven by biotech drugs, Decision Resources finds
BURLINGTON, Mass. — Biotech drugs will help drive the markets for acute and chronic gout through 2019, according to a new report by market research firm Decision Resources.
The report, titled “Acute and Chronic Gout — New Agents Target Refractory Patients and Tap Market Opportunity,” found that the acute gout drug market would triple in size to $117 million, while the chronic gout market would reach $1.83 billion.
High-priced biotech drugs would help drive the market. The latest approved drug for chronic gout is Savient Pharmaceuticals’ Krystexxa (pegloticase), while Novartis’ Ilaris (canakinumab) and Regeneron’s Arcalyst (rilonacept) are under development for acute gout.
“These high-priced agents will be reserved for small segments of the population,” Decision Resources analyst Matthew Scutcher said. “Krystexxa will be used predominantly in patients with severe treatment-refractory chronic gout, while Ilaris and Acalyst will likely be used adjunctively with uricase-lowering treatment for patients who experience severe and frequent acute attacks.”
Poll: Medicare Part D beneficiaries unaware of measures to close ‘doughnut hole’
WASHINGTON — Most beneficiaries of the Medicare Part D program are unaware of new measures to close the so-called “doughnut hole” coverage gap, according to a recent poll.
The survey of 1,243 beneficiaries, commissioned by the Medicare Today coalition and conducted by KRC Research, found that 1-in-5 seniors know that eligible beneficiaries who have drug spending that places them in the doughnut hole — a point when beneficiaries’ drug costs pass a limit and leave them responsible for the entire cost — will receive a 50% discount on branded drugs starting next year.
Medicare Today co-chairwoman Mary Grealy said the survey research showed a need for continued outreach to beneficiaries by the public and private sectors.
Kroger aids underinsured, uninsured customers with free flu shot vouchers
CINCINNATI — In an effort to assure that its customers stay healthy this holiday season, Kroger is offering free flu shot vouchers to the Salvation Army and Feeding America, a leading domestic hunger-relief organization.
Underinsured or uninsured shoppers in areas with a Kroger or a Kroger banner pharmacy — including City Market, Dillons, Jay C, Fred Meyer, Fry’s, King Soopers, QFC, Ralphs and Smith’s — are eligible. The flu shot vouchers also can be redeemed at The Little Clinic, Kroger’s retail health clinic chain that operates in 77 stores under the Kroger, Fry’s and King Soopers banners.
The vouchers are available at the Salvation Army and local Feeding America food banks.
"We’re proud of the role our pharmacists and nurse practitioners play in keeping our customers healthy," said Lincoln Lutz, Kroger VP pharmacy. "Kroger has long partnerships with Feeding America and the Salvation Army and we’re pleased we can work together again during the flu season to promote health and wellness through these free flu shot vouchers."